Moxonidine Tablet - 0.2 Mg, 0.3 Mg | Blood Pressure Management, Stroke And Heart Attack Prevention, Multi-medication Support

This is to introduce ourselves as a professionally managed fast growing Pharmaceutical Company having more than Five Years of Manufacturing and Marketing experience. We are based at Mumbai in the State of Maharashtra. The Company has been accredited with ISO-9001:2008 and manufactures pharmaceutical formulations as per the guidelines of WHO. It is a (GMP Certified) Unit with total quality management and In-house Testing Laboratory. Our success is the result of focusing on our clients top priorities such as quality products, on-time delivery, competitive rates and unparalleled responsiveness. Johnlee manufactures more than 400 plus Pharmaceutical Formulation Products in the form of Tablets, Capsules, Dry syrup, Liquid Orals and Sustained Release Preparations. It is the Company constant and Company will also increasingly focus in high growth potential segments like Vaccines and Biogenetics. These new areas will add significant depth to the existing product pipeline. The proteasome has been validated as an important clinical target in cancer, and Johnlee Pharmaceuticals Pvt. Ltd. is developing next-generation proteasome inhibitors with a high degree of selectivity, with the goal of increasing therapeutic efficacy and reducing side effects.